Spiral wound filtration assembly including integral bioreactor

US10358366B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10358366-B2
Application numberUS-201715630204-A
CountryUS
Kind codeB2
Filing dateJun 22, 2017
Priority dateSep 24, 2014
Publication dateJul 23, 2019
Grant dateJul 23, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A spiral wound filtration assembly including: i) a pressure vessel comprising a feed port, concentrate port and permeate port; ii) at least one spiral wound membrane module comprising at least one membrane envelop wound around a permeate tube which forms a permeate pathway to the permeate port; and iii) a bioreactor having a cylindrical outer periphery extending along an axis (Y) from a first end to a second end, an inlet located near the first end, and an outlet located near the second end; wherein the spiral wound membrane module and bioreactor are serially arranged within the pressure vessel.

First claim

Opening claim text (preview).

The invention claimed is: 1. A spiral wound filtration assembly comprising: i) a pressure vessel comprising a feed port, concentrate port and permeate port; ii) at least one spiral wound membrane module comprising at least one membrane envelop wound around a permeate tube which forms a permeate pathway to the permeate port; and iii) a bioreactor having a cylindrical outer periphery extending along an axis (Y) from a first end to a second end, an inlet located near the first end, and an outlet located near the second end; wherein the bioreactor has a spiral wound configuration comprising a flat sheet having two opposing bio-growth surfaces and a feed spacer spirally wound about the axis (Y); wherein the feed spacer defines flow channels extending along both of the two opposing bio-growth surfaces of the flat sheet from the inlet to the outlet of the bioreactor; and wherein the spiral wound membrane module and bioreactor are serially arranged within the pressure vessel. 2. The assembly of claim 1 wherein the flat sheet is permeable and the two opposing bio-growth surfaces are in fluid communication with each other. 3. The assembly of claim 1 wherein the flat sheet and feed spacer are spirally wound about a hollow conduit, wherein the conduit is sealed from fluid communication with the flat sheet and feed spacer and is serially connected to the permeate tube of the spiral wound membrane module. 4. The assembly of claim 1 further comprising a plurality of spiral wound membrane modules, each comprising at least one membrane envelop wound around a permeate tube, and wherein the spiral wound membrane modules are serially arranged within the pressure vessel with a first element of the series positioned nearest to a first end of the pressure vessel and a last element of the series positioned adjacent to an opposing second end of the pressure vessel, and wherein the permeate tubes of the spiral wound elements are serially connected to form a permeate pathway which is connected to the permeate outlet, and wherein the bioreactor is arranged within said series at a location upstream of at least one spiral wound membrane module. 5. The assembly of claim 4 wherein the bioreactor is arranged within the series at a location upstream of all spiral wound membrane modules. 6. The assembly of claim 1 wherein the feed spacer of the bioreactor provides flow channels of from 0.10 mm to 1.5 mm between adjacent bio-growth surfaces of the flat sheet. 7. The assembly of claim 1 wherein the flow channels have a void volume between bio-growth surfaces that is not occupied by a solid, and wherein the void volume of the flow channels is at least 65% of the volume of the bioreactor.

Assignees

Inventors

Classifications

  • Biological processes · CPC title

  • Membrane bioreactor systems · CPC title

  • comprising multiple spiral-wound assemblies · CPC title

  • Feed pretreatment · CPC title

  • C02F3/109Primary

    Characterized by the shape (C02F3/104 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10358366B2 cover?
A spiral wound filtration assembly including: i) a pressure vessel comprising a feed port, concentrate port and permeate port; ii) at least one spiral wound membrane module comprising at least one membrane envelop wound around a permeate tube which forms a permeate pathway to the permeate port; and iii) a bioreactor having a cylindrical outer periphery extending along an axis (Y) f…
Who is the assignee on this patent?
Dow Global Technologies Llc
What technology area does this patent fall under?
Primary CPC classification C02F3/109. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).